Authorities in the European Union (EU) have agreed to review Kalvista Pharmaceuticals’ application requesting the approval of oral…
Articles by Marisa Wexler, MS
Astria Therapeutics is teaming up with Ypsomed, a Swiss-based company, to develop an autoinjector for its experimental treatment…
A single dose of the gene-editing therapy NTLA-2002 led to significant reductions in the number of swelling attacks among…
The oral medication Orladeyo (berotralstat) is now approved in Peru as a prophylactic, or preventive, treatment to reduce the…
KalVista Pharmaceuticals has started a clinical trial to test the oral medication sebetralstat as an on-demand treatment for…
Most hereditary angioedema (HAE) patients are able to take on-demand oral tablets of sebetralstat within 10 minutes of…
Genetic variants in the CC2D2B gene may affect disease severity in hereditary angioedema (HAE) types 1 and 2, according…
The unusual case of a woman with drug-induced angioedema that led to a rare complication called acute compartment syndrome…
The once-daily oral therapy Orladeyo (berotralstat) has been approved in Brazil to prevent swelling attacks in people, 12 and…
Treatment with the experimental under-the-skin injection therapy STAR-0215 reduced the rates of monthly swelling attacks by more than 90%…